Investigating how lifespan interventions can affect Alzheimer's disease progression
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
This study is looking for new ways to help prevent Alzheimer's disease by understanding how inflammation affects the brain as we age, and it invites people to join trials that could lead to better treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10809761 on NIH RePORTER |
What this research studies
This research aims to identify new therapeutic agents that can prevent the onset and progression of Alzheimer's disease (AD). It focuses on understanding the mechanisms behind the dysregulation of the autophagy-inflammation network, which is believed to contribute to both aging and AD. By targeting systemic inflammation, the researchers hope to develop interventions that could delay the onset of Alzheimer's and improve overall health during aging. Patients may have the opportunity to participate in trials that explore these innovative approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those in the early stages of cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those with other unrelated severe cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly alter the course of Alzheimer's disease and enhance the quality of life for patients.
How similar studies have performed: Previous research has shown promise in targeting inflammation and autophagy in neurodegenerative diseases, suggesting potential for success in this novel approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Rizzo, Stacey J — University of Pittsburgh at Pittsburgh
- Study coordinator: Rizzo, Stacey J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.